Trial Profile
Multicenter, Randomized, Open-label, Parallel-group Study to Compare mLSG15 + KW-0761 to mLSG15 in Subjects With CCR4-positive Adult T-cell Leukemia-lymphoma (Untreated Primary Disease).
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Mogamulizumab (Primary) ; Carboplatin; Cyclophosphamide; Doxorubicin; Etoposide; Prednisolone; Ranimustine; Vincristine; Vindesine
- Indications Adult T-cell leukaemia-lymphoma
- Focus Therapeutic Use
- Sponsors Kyowa Hakko Kirin; Kyowa Kirin
- 16 Dec 2019 Results assessing population pharmacikinetic modeling by using data from six studies including this study published in the Journal of Clinical Pharmacology.
- 01 Jun 2015 Results published in the British Journal of Haematology.
- 23 Jul 2013 Results published in a Kyowa Hakko Kirin media release; this trial supports an application for approval of mogamulizumab in a new indication